These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25487260)

  • 1. Advances of knowledge on allergic inflammation and the oral mucosa.
    Incorvaia C; Fuiano N; Frati F; Marcucci F
    Recent Pat Inflamm Allergy Drug Discov; 2014; 8(3):173-7. PubMed ID: 25487260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergic inflammation and the oral mucosa.
    Incorvaia C; Frati F; Sensi L; Riario-Sforza GG; Marcucci F
    Recent Pat Inflamm Allergy Drug Discov; 2007 Feb; 1(1):35-8. PubMed ID: 19075964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sublingual immunotherapy on allergic inflammation.
    Incorvaia C; Frati F; Puccinelli P; Marcucci F; Di Cara G; Sensi L; Scurati S; Yacoub MR; Moingeon P
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):167-72. PubMed ID: 18782023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sublingual immunotherapy on allergic inflammation: an update.
    Yacoub MR; Colombo G; Marcucci F; Caminati M; Sensi L; Di Cara G; Frati F; Incorvaia C
    Inflamm Allergy Drug Targets; 2012 Aug; 11(4):285-91. PubMed ID: 22506880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization application to allergic disease: sublingual immunotherapy.
    Frati F; Moingeon P; Marcucci F; Puccinelli P; Sensi L; Di Cara G; Incorvaia C
    Allergy Asthma Proc; 2007; 28(1):35-9. PubMed ID: 17390755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local immunological mechanisms of sublingual immunotherapy.
    Allam JP; Novak N
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):571-8. PubMed ID: 22001742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose dependence of efficacy but not of safety in sublingual immunotherapy.
    Frati F; Incorvaia C; Marcucci F; Sensi L; Di Cara G; Puccinelli P; Dal Bo S
    Monaldi Arch Chest Dis; 2006 Mar; 65(1):38-40. PubMed ID: 16700192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
    Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
    Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological mechanisms of sublingual allergen-specific immunotherapy.
    Novak N; Bieber T; Allam JP
    Allergy; 2011 Jun; 66(6):733-9. PubMed ID: 21251016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic aspects of sublingual immunotherapy in the treatment of allergy and asthma.
    Bahceciler NN; Ozdemir C; Barlan IB
    Curr Med Chem; 2007; 14(3):265-9. PubMed ID: 17305531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune privilege of the oral mucosa.
    Novak N; Haberstok J; Bieber T; Allam JP
    Trends Mol Med; 2008 May; 14(5):191-8. PubMed ID: 18396104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal dendritic cells in allergy and immunotherapy.
    Novak N; Allam JP
    Allergy; 2011 Jul; 66 Suppl 95():22-4. PubMed ID: 21668846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen-specific immunotherapy: an update on immunological mechanisms of action.
    Ciprandi G; Marseglia GL; Tosca MA
    Monaldi Arch Chest Dis; 2006 Mar; 65(1):34-7. PubMed ID: 16700191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction.
    Saint-Lu N; Tourdot S; Razafindratsita A; Mascarell L; Berjont N; Chabre H; Louise A; Van Overtvelt L; Moingeon P
    Allergy; 2009 Jul; 64(7):1003-13. PubMed ID: 19220212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy.
    van de Veen W; Wirz OF; Globinska A; Akdis M
    Curr Opin Immunol; 2017 Oct; 48():74-81. PubMed ID: 28888176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting dendritic cells in allergen immunotherapy.
    Novak N
    Immunol Allergy Clin North Am; 2006 May; 26(2):307-19, viii. PubMed ID: 16701146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
    Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA
    J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of inflammatory cells in the oral mucosa of subjects undergoing sublingual immunotherapy.
    Marcucci F; Incorvaia C; Sensi L; Di Cara G; Cadario G; Cavaliere A; Moingeon P; Puccinelli P; Di Gioacchino M; Frati F
    Int J Immunopathol Pharmacol; 2008; 21(3):609-13. PubMed ID: 18831928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation.
    O'Hehir RE; Sandrini A; Anderson GP; Rolland JM
    Curr Med Chem; 2007; 14(21):2235-44. PubMed ID: 17896972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.